Synthesis of atypical carotenoids: self-preserving inhibitors of lipid peroxidati
Synthesis of atypical carotenoids: self-preserving inhibitors of lipid peroxidati
批准号:
7767348
负责人:
Martin D Burke
金额:
$30.07万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2013-11-30
关键词:
AddressAgeAge related macular degenerationAntioxidantsArthritisArtsAsthmaAtherosclerosisAttenuatedBiochemicalBiological FactorsCaroteneCarotenoidsCell membraneCellsChemicalsClinical TrialsCollectionCombinatorial SynthesisCommunitiesComplexConduct Clinical TrialsCouplingDevelopmentDiabetes MellitusDiseaseEmployee StrikesFigs - dietaryFoundationsFunctional disorderFutureGenerationsGoalsHandHealthHumanIn VitroInvestigationKnowledgeLeadLettersLipid BilayersLipid PeroxidationLipidsLiposomesLuteinMacular degenerationMalignant NeoplasmsMalignant neoplasm of lungMembraneMembrane LipidsMethodsModificationNeurodegenerative DisordersOxygenPhospholipidsPlantsPolyenesPreparationPrincipal InvestigatorProcessPropertyPublicationsReactive Oxygen SpeciesReperfusion InjuryResearchRheumatoid ArthritisRoleRouteSafetyScreening procedureSeriesStructureStructure-Activity RelationshipTestingTherapeutic AgentsTimeVeinsanalogastaxanthinebaseclinical effectcombinatorial chemistrydesignflexibilityheart disease preventionhigh throughput screeninghuman diseaseimprovedin vivoinhibitor/antagonistinterestlipid peroxidation inhibitormicroorganismnovelnovel therapeuticsoxidative damageperoxidationpre-clinicalprogramsprotective effectpublic health relevancesmall moleculezeaxanthin
中文摘要
非典型类胡萝卜素的合成:自我保存的脂质过氧化抑制剂安全有效地抑制脂质双分子层过氧化的小分子有望极大地推进许多常见人类疾病的治疗,包括动脉粥样硬化、癌症、黄斑变性和关节炎。然而,大多数已知的O型抗脂过氧化剂都有重要的局限性。例如,典型的类胡萝卜素如O虾青素具有很强的自我Me HO Me peridinin (1) Me OAc与活性氧Me的破坏性相互作用倾向,这限制了脂质O保护作用的寿命,导致产生HO Me Me有害的类胡萝卜素分解产物。相比之下,最近发现了几种Me Me Me Me Me OH“非典型”类胡萝卜素,它们通过Me O协同黄质(2)自我保护机制具有特殊的抗脂质过氧化活性。具体地说,这个研究项目将开发的高效和灵活的合成HO O O O我非典型类胡萝卜素peridinin(1),何鸿燊O我synechoxanthin(2),和di - [(6-O-oleoyl-2-D - HO我我我我glucopyranosyl)氧)虾青素(3),执行我我我我我系统的结构/功能研究O O OO哦了解他们独特的antilipoperoxidant概要文件,并通过合理引导的组合合成和高二-[(6-O-油基-)]的迭代循环广泛优化其Me O OH活性。- d -葡萄糖吡喃基氧[-虾青素(3)通量筛选。小灵通398/2590 (Rev. 05/01)页延续格式页
英文摘要
DESCRIPTION (provided by applicant): Project Summary Synthesis of atypical carotenoids: self-preserving inhibitors of lipid peroxidation Small molecules that safely and effectively inhibit the peroxidation of lipid bilayers stand to substantially advance the treatment of many prevalent human diseases, including atherosclerosis, cancer, macular degeneration, and arthritis. However, most of the known O antilipoperoxidants have important limitations. Me Me O Me H HO Me For example, typical carotenoids such as O astaxanthin have a strong propensity for self- Me HO Me peridinin (1) Me OAc destructive interactions with reactive oxygen Me species, which limits the lifetime of the lipid O protective effect and leads to the generation of HO Me Me harmful carotenoid breakdown products. In contrast, there are several recently discovered Me Me Me Me OH "atypical" carotenoids that have the potential Me for exceptional antilipoperoxidant activities via Me O synechoxanthin (2) self-preserving mechanisms of action. Specifically, this research program will develop O highly efficient and flexible syntheses of the HO O O O Me atypical carotenoids peridinin (1), HO O Me synechoxanthin (2), and di-[(6-O-oleoyl-2-D- HO Me Me Me Me glucopyranosyl)oxy]-astaxanthin (3), execute Me Me Me Me systematic structure/function studies to Me O O OO OH understand their unique antilipoperoxidant OH profiles, and extensively optimize their Me O OH activities via iterative cycles of rationally- guided combinatorial synthesis and high- di-[(6-O-oleoyl-!-D-glucopyranosyl)oxy]-astaxanthin (3) throughput screening. PHS 398/2590 (Rev. 05/01) Page Continuation Format Page
PUBLIC HEALTH RELEVANCE: Project Narrative Synthesis of atypical carotenoids: self-preserving inhibitors of lipid peroxidation Several recently discovered natural products have the potential to serve as powerful antioxidants inside cell membranes, and therefore may lead to improved treatments for a variety of prevalent diseases, including atherosclerosis, cancer, and arthritis. In contrast to related antioxidants that have been studied previously, these new compounds do not self-destruct as they protect the membrane from oxidative damage, which is critical for maximizing efficacy and safety. This research program will lead to the efficient synthesis, detailed study, and extensive optimization of these novel "self-preserving" antioxidants. PHS 398/2590 (Rev. 05/01) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using a small molecule iron transporter to understand and treat FPN1 deficiencies in mice
-
批准号:10181021
-
项目类别:
-
资助金额:$67.57万
-
财政年份:2018
-
负责人:Martin D Burke
-
依托单位:
Using a small molecule iron transporter to understand and treat FPN1 deficiencies in mice
-
批准号:9756457
-
项目类别:
-
资助金额:$70.4万
-
财政年份:2018
-
负责人:Martin D Burke
-
依托单位:
Molecular Prosthetics and Lego Chemistry
-
批准号:10552238
-
项目类别:
-
资助金额:$71.61万
-
财政年份:2016
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:7929731
-
项目类别:
-
资助金额:$8.5万
-
财政年份:2009
-
负责人:Martin D Burke
-
依托单位:
Synthesis of atypical carotenoids: self-preserving inhibitors of lipid peroxidati
-
批准号:8391733
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2009
-
负责人:Martin D Burke
-
依托单位:
Synthesis of atypical carotenoids: self-preserving inhibitors of lipid peroxidati
-
批准号:7993589
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2009
-
负责人:Martin D Burke
-
依托单位:
Synthesis of atypical carotenoids: self-preserving inhibitors of lipid peroxidati
-
批准号:8197629
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2009
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:8505913
-
项目类别:
-
资助金额:$24.91万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:8078988
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:7563730
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:7841690
-
项目类别:
-
资助金额:$28.92万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:8643792
-
项目类别:
-
资助金额:$39.09万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:8659136
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:7470720
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:8995207
-
项目类别:
-
资助金额:$44.58万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:7322462
-
项目类别:
-
资助金额:$29.41万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:7625203
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
Synthesis and Study of Amphotericin B Derivatives
-
批准号:8792848
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2007
-
负责人:Martin D Burke
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: